Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Pigment Cell Research
|
May 1, 1989
Repigmentation of vitiliginous skin by cultured cells
M M Brysk, R C Newton, S Rajaraman, et al.
Archives of Dermatology
|
February 1, 1986
Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus
R C Newton, J L Jorizzo, A R Solomon, et al.
Annals of the Rheumatic Diseases
|
March 14, 2002
Biology of TACE inhibition
R C Newton, K A Solomon, M B Covington, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 1, 1991
Internalization and nuclear localization of interleukin 1 are not sufficient for function
A Heguy, C Baldari, K Bush, et al.
Molecular Biology & Medicine
|
June 1, 1987
High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta
J J Huang, R C Newton, K Pezzella, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Aggrecanase. A target for the design of inhibitors of cartilage degradation
E C Arner, M A Pratta, C P Decicco, et al.
Archives of Oral Biology
|
May 1, 1996
Association of interleukin-1-induced, NF kappa B DNA-binding activity with collagenase gene expression in human gingival fibroblasts
M Tewari, O C Tuncay, A Milchman, et al.
Journal of Medicinal Chemistry
|
May 14, 1993
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis
D G Batt, R Goodman, D G Jones, et al.
Protein Engineering
|
July 1, 1992
Permuteins of interleukin 1 beta--a simplified approach for the construction of permutated proteins having new termini
R A Horlick, H J George, G M Cooke, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists
R M DiPardo, M A Patane, R C Newton, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Pigment Cell Research
|
May 1, 1989
Repigmentation of vitiliginous skin by cultured cells
M M Brysk, R C Newton, S Rajaraman, et al.
Archives of Dermatology
|
February 1, 1986
Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus
R C Newton, J L Jorizzo, A R Solomon, et al.
Annals of the Rheumatic Diseases
|
March 14, 2002
Biology of TACE inhibition
R C Newton, K A Solomon, M B Covington, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 1, 1991
Internalization and nuclear localization of interleukin 1 are not sufficient for function
A Heguy, C Baldari, K Bush, et al.
Molecular Biology & Medicine
|
June 1, 1987
High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta
J J Huang, R C Newton, K Pezzella, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Aggrecanase. A target for the design of inhibitors of cartilage degradation
E C Arner, M A Pratta, C P Decicco, et al.
Archives of Oral Biology
|
May 1, 1996
Association of interleukin-1-induced, NF kappa B DNA-binding activity with collagenase gene expression in human gingival fibroblasts
M Tewari, O C Tuncay, A Milchman, et al.
Journal of Medicinal Chemistry
|
May 14, 1993
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis
D G Batt, R Goodman, D G Jones, et al.
Protein Engineering
|
July 1, 1992
Permuteins of interleukin 1 beta--a simplified approach for the construction of permutated proteins having new termini
R A Horlick, H J George, G M Cooke, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists
R M DiPardo, M A Patane, R C Newton, et al.
Page
of 7